Completed NA INTERVENTIONAL 3-arm NCT00435864

Natural Killer Index From Hematopoietic Stem Cell Graft

Pilot, Multicenter and Prospective Study of the Natural Killer Index From Hematopoietic Stem Cell Graft at a Genotypic, Phenotypic and Functional Level

Sponsor: Nantes University Hospital

Conditions Acute Lymphoblastic Leukemia Acute Myeloblastic Leukemia Chronic Myeloid Leukemia

Interventions Blood test

Updated 5 times since 2017 Last updated: Apr 29, 2014 Started: Apr 30, 2007 Primary completion: Nov 30, 2013 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Lymphoblastic Leukemia and Acute Myeloblastic Leukemia and is currently completed. Nantes University Hospital leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nantes University Hospital

Data source: Nantes University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nantes, France